EXANE DERIVATIVES - MANNKIND CORP ownership

MANNKIND CORP's ticker is MNKD and the CUSIP is 56400P706. A total of 109 filers reported holding MANNKIND CORP in Q4 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of MANNKIND CORP
ValueSharesWeighting
Q4 2021$000.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$0
-100.0%
0
-100.0%
0.00%
Q3 2020$15,000
+7.1%
80.0%0.00%
Q2 2020$14,000
+75.0%
80.0%0.00%
Q1 2020$8,000
-33.3%
80.0%0.00%
Q4 2019$12,000
+20.0%
80.0%0.00%
Q3 2019$10,000
+11.1%
80.0%0.00%
Q2 2019$9,000
-43.8%
80.0%0.00%
Q1 2019$16,000
+100.0%
80.0%0.00%
Q4 2018$8,000
-46.7%
80.0%0.00%
Q3 2018$15,0000.0%80.0%0.00%
Q2 2018$15,000
-25.0%
80.0%0.00%
Q1 2018$20,000
+5.3%
80.0%0.00%
Q4 2017$19,000
+11.8%
80.0%0.00%
Q3 2017$17,000
+54.5%
80.0%0.00%
Q2 2017$11,000
-8.3%
80.0%0.00%
Q1 2017$12,00080.00%
Other shareholders
MANNKIND CORP shareholders Q4 2017
NameSharesValueWeighting ↓
1492 Capital Management LLC 533,828$2,333,0001.15%
180 WEALTH ADVISORS, LLC 1,037,426$3,932,0000.88%
EMERALD ADVISERS, LLC 5,217,037$22,798,0000.84%
EMERALD MUTUAL FUND ADVISERS TRUST 4,648,971$20,316,0000.72%
Avoro Capital Advisors LLC 8,800,000$38,456,0000.65%
Monarch Partners Asset Management LLC 420,478$1,837,0000.37%
DG Capital Management, LLC 511,562$2,236,0000.37%
Bruce & Co., Inc. 395,073$1,726,0000.34%
SCOPIA CAPITAL MANAGEMENT LP 694,961$3,037,0000.29%
Parkman Healthcare Partners LLC 265,855$1,162,0000.26%
View complete list of MANNKIND CORP shareholders